BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18381567)

  • 41. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
    Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
    Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
    Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic nitroglycerin did not reduce myocardial ischemia during accelerated recovery management of coronary artery bypass graft surgery patients.
    Zvara DA; Groban L; Rogers AT; Prielipp RC; Murphy B; Hines M; Hammon JW; Kon ND; Royster RL
    J Cardiothorac Vasc Anesth; 2000 Oct; 14(5):571-5. PubMed ID: 11052441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial.
    Hulzebos EH; Helders PJ; Favié NJ; De Bie RA; Brutel de la Riviere A; Van Meeteren NL
    JAMA; 2006 Oct; 296(15):1851-7. PubMed ID: 17047215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial.
    Riedel BJ; Gal J; Ellis G; Marangos PJ; Fox AW; Royston D
    Anesth Analg; 2004 Jan; 98(1):20-29. PubMed ID: 14693576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
    Mitchell LB; Exner DV; Wyse DG; Connolly CJ; Prystai GD; Bayes AJ; Kidd WT; Kieser T; Burgess JJ; Ferland A; MacAdams CL; Maitland A
    JAMA; 2005 Dec; 294(24):3093-100. PubMed ID: 16380589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
    Jain U; Laflamme CJ; Aggarwal A; Ramsay JG; Comunale ME; Ghoshal S; Ngo L; Ziola K; Hollenberg M; Mangano DT
    Anesthesiology; 1997 Mar; 86(3):576-91. PubMed ID: 9066323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Moderate hyperoxic versus near-physiological oxygen targets during and after coronary artery bypass surgery: a randomised controlled trial.
    Smit B; Smulders YM; de Waard MC; Boer C; Vonk AB; Veerhoek D; Kamminga S; de Grooth HJ; García-Vallejo JJ; Musters RJ; Girbes AR; Oudemans-van Straaten HM; Spoelstra-de Man AM
    Crit Care; 2016 Mar; 20():55. PubMed ID: 26968380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation?
    Karuppasamy P; Chaubey S; Dew T; Musto R; Sherwood R; Desai J; John L; Shah AM; Marber MS; Kunst G
    Basic Res Cardiol; 2011 Jun; 106(4):511-9. PubMed ID: 21544683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes.
    Kamalesh M; Sharp TG; Tang XC; Shunk K; Ward HB; Walsh J; King S; Colling C; Moritz T; Stroupe K; Reda D;
    J Am Coll Cardiol; 2013 Feb; 61(8):808-16. PubMed ID: 23428214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial.
    Kosova EC; Bonaca MP; Dellborg M; He P; Morais J; Oude Ophuis T; Scirica BM; Tendera M; Theroux P; Braunwald E; Morrow DA
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):164-172. PubMed ID: 27075924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.
    Kandzari DE; Dery JP; Armstrong PW; Douglas DA; Zettler ME; Hidinger GK; Friesen AD; Harrington RA
    Expert Opin Investig Drugs; 2005 Nov; 14(11):1435-42. PubMed ID: 16255681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonsteroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery.
    de Souza Brito F; Mehta RH; Lopes RD; Harskamp RE; Lucas BD; Schulte PJ; Tardif JC; Alexander JH
    Am J Med; 2017 Apr; 130(4):462-468. PubMed ID: 27888052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial.
    Garg AX; Devereaux PJ; Yusuf S; Cuerden MS; Parikh CR; Coca SG; Walsh M; Novick R; Cook RJ; Jain AR; Pan X; Noiseux N; Vik K; Stolf NA; Ritchie A; Favaloro RR; Parvathaneni S; Whitlock RP; Ou Y; Lawrence M; Lamy A;
    JAMA; 2014 Jun; 311(21):2191-8. PubMed ID: 24886787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery.
    Cywinski JB; Koch CG; Krajewski LP; Smedira N; Li L; Starr NJ
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):796-802. PubMed ID: 17138083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of colchicine to reduce perioperative myocardial damage in patients who underwent on-pump coronary artery bypass grafting.
    Giannopoulos G; Angelidis C; Kouritas VK; Dedeilias P; Filippatos G; Cleman MW; Panagopoulou V; Siasos G; Tousoulis D; Lekakis J; Deftereos S
    Am J Cardiol; 2015 May; 115(10):1376-81. PubMed ID: 25784519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.